As we know, Axiron is marketed by Eli Lilly. One would have thought if you are going to outsource your sales and marketing, you would enter into an agreement with that organization which motivates them to sell more. Unfortunately in our case, we have an agreement which penalises Lilly if they sell much more Axiron, as they they have to cut Acrux a fat cheque (bonus payment). Why would Lilly expend resources on selling more?
Add to My Watchlist
What is My Watchlist?
